Compare Charles Schwab Corporation Common Stock (SCHW) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Charles Schwab Corporation Common Stock trades at $92.97 (market cap $167.40B), while Vir Biotechnology Inc. Common Stock trades at $10.52 (market cap $1.76B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 95.1× Vir Biotechnology Inc. Common Stock's market cap, and Charles Schwab Corporation Common Stock pays a 1.32% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles Schwab Corporation Common Stock for 86 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SCHW | VIR | |
|---|---|---|
Market Cap | $167.40B | $1.76B |
Volume | 13,127,509 | 2,764,948 |
Sector | Financials | Health |
52-Week High | $113.65 | $11.78 |
52-Week Low | $85.35 | $5.12 |
Typical Hold Time | 86 Days | 0 Days |
Enterprise Value | $152.90B | $1.32B |
Dividend Yield | 1.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles Schwab (SCHW) trades at $95.94, down 1.15% with a bearish technical outlook despite strong fundamentals. The company reported robust earnings beats in recent quarters with Q2 2026 EPS of $1.62 exceeding expectations of $1.56. Revenue growth accelerated to $23.92 billion in 2025 with net income margins reaching 38.79%. Analyst consensus remains bullish with a $120.69 price target representing 26% upside potential.
Schwab's strong earnings momentum and AI integration initiatives provide growth catalysts, though technical weakness and competitive pressures present near-term risks. The stock offers attractive valuation at 17.63 P/E with solid profitability metrics including 22.45% ROE. Market sentiment is positive driven by record client assets and strategic expansion including dual listing on Texas Stock Exchange.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
